CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in IDYA — IDEAYA Biosciences, Inc.
CIK 884546
SAN FRANCISCO, CA
Position in IDYA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$23,841,359
-$863,503 QoQ
Shares Held
715,527
+0.1% QoQ
Ownership
0.814%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in IDYA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $6,182,986,350 across 288 Biotechnology names. IDYA ranks #53 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,920,871 | $857,745,736 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
804,508 | $621,595,061 | |
| 3 | MRNA |
Moderna, Inc.
|
4,734,356 | $240,505,284 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
673,356 | $222,793,299 | |
| 5 | INSM |
INSMED Inc
|
1,069,390 | $174,866,652 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
1,735,476 | $168,775,041 | |
| 7 | INCY |
Incyte Corp
|
1,729,102 | $162,743,080 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,976,094 | $146,744,740 |
All Filings in IDYA
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $23,841,359 | 715,527 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $24,704,862 | 714,633 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $19,469,788 | 715,538 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $15,067,093 | 716,798 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $11,526,868 | 703,716 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $18,319,242 | 712,811 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $21,829,832 | 689,073 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $21,436,586 | 610,555 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $24,993,565 | 569,589 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $17,663,904 | 496,456 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $11,799,864 | 437,356 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $3,433,726 | 146,116 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $1,636,657 | 119,203 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $2,146,567 | 118,138 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $1,368,223 | 91,704 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,253,302 | 90,819 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $957,550 | 85,572 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $1,973,065 | 83,463 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $2,120,385 | 83,185 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $1,377,699 | 65,636 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $1,029,817 | 43,822 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $548,912 | 39,208 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $492,452 | 39,208 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $368,365 | 25,923 | Shares | Sole | 2020-08-20 | |
| No filing history on record for this holder in this stock. | ||||||